CIMG Inc. Faces Heightened Delisting Risk After New Nasdaq Non-Compliance

This is a critical update on your investment in CIMG Inc., explained clearly and without jargon. Let's understand the serious situation unfolding.

---

Event Description (what happened)

The Core Issue: Double Trouble with Nasdaq

CIMG Inc. has received another serious notice from Nasdaq, the stock exchange where its shares trade. This latest warning, issued on February 23, 2026, is for failing to file its quarterly financial report (Form 10-Q) for the quarter ended December 31, 2025, on time. This isn't just a minor slip-up; it violates Nasdaq Listing Rule 5250(c)(1) and adds another reason for delisting the company's stock.

This new issue worsens an existing delisting threat. CIMG was already under a "Mandatory Panel Monitor" by Nasdaq – a form of probation – stemming from a prior compliance problem (e.g., failure to meet minimum bid price requirements). This means the company now faces two distinct, serious challenges to its continued listing on Nasdaq. CIMG announced this new development publicly on February 27, 2026.

Event Date/Timeline

The Timeline and Details

• Previous Delisting Threat (December 4, 2025): Nasdaq had previously issued CIMG a Staff Delisting Determination for violating a different listing rule. CIMG appealed this decision. The Nasdaq Hearings Panel then granted an exception to continue listing, but with specific conditions.
• Mandatory Panel Monitor: These conditions included a "Mandatory Panel Monitor" until November 14, 2026. During this time, CIMG had to regain compliance with the initial rule and remain fully compliant with all other Nasdaq listing rules.
• Missed Financial Filing (February 14, 2026): The Form 10-Q for the quarter ending December 31, 2025, was due by February 14, 2026, but CIMG failed to submit it.
• New Delisting Basis (February 23, 2026): Because CIMG filed the 10-Q late, Nasdaq sent a new letter on February 23, 2026. This letter formally notified CIMG of the additional deficiency and its delisting implications.
• Reason for Delay: CIMG stated it needs more time to complete its financial statements and disclosures. However, it has not explained the specific reasons for the delay (e.g., audit issues, internal control problems, restatements).

Impact Assessment (who/what is affected)

Why This is Critical for Investors

• Heightened Delisting Risk: CIMG is now in "double jeopardy." The late 10-Q is a new, serious violation. The Nasdaq Hearings Panel will consider it alongside CIMG's existing compliance issues. This significantly increases the chance Nasdaq will remove CIMG's stock from the exchange.
• Total Information Blackout: Without the Q4 2025 Form 10-Q, investors lack crucial information about CIMG's recent financial performance. You lack vital data on revenue, expenses, profit/loss, cash flow, and balance sheet health. This makes it impossible to accurately assess the company's value or make informed investment decisions.
• Erosion of Trust and Governance Concerns: Repeated compliance failures and a lack of transparency signal potential operational, financial, or governance weaknesses within the company. This severely damages investor confidence and raises questions about management's ability to run the business effectively and meet regulatory standards.
• Operational and Strategic Impact: Delisting would severely restrict CIMG's ability to raise capital, attract and retain talent, and execute its long-term business strategy. This could impact its ability to deliver products or services to customers.

What Happens Next

• Nasdaq Hearings Panel Review: The Nasdaq Hearings Panel will now consider this new deficiency as part of CIMG's ongoing appeal and monitoring process. This could lead to an expedited decision or additional conditions.
• Filing the Overdue 10-Q: CIMG must file the overdue Form 10-Q as quickly as possible. Nasdaq typically gives companies a specific deadline (often 60 days) to fix such deficiencies. Filing it sooner might lessen the severity of the Panel's decision.
• Compliance with Existing Monitor: CIMG must still meet all original conditions of its "Mandatory Panel Monitor" by November 14, 2026. This is in addition to addressing the new late filing. Any further missteps could lead to immediate delisting.
• Potential Outcomes: The Panel has several options: granting a further extension (unlikely given the new deficiency), imposing additional stringent conditions, or, most severely, issuing a final delisting order.

Financial Impact (if applicable)

• Inability to Assess Current Financials: Because CIMG failed to file the Form 10-Q, the filing does not disclose the company's current financial performance (revenue, expenses, profit/loss, cash flow, and balance sheet health for Q4 2025). This lack of information prevents investors from accurately assessing CIMG's finances.
• Potential for Impaired Capital Raising: Delisting from Nasdaq would significantly restrict CIMG's ability to raise capital through public markets. This would impact its financial flexibility and growth prospects.
• Decline in Stock Value and Liquidity: If delisted, CIMG's shares would likely move to less regulated over-the-counter (OTC) markets. This typically results in a substantial decline in stock value and liquidity.

Key Takeaways for Investors

Your Practical Takeaways as an Investor

• Extreme Risk and Uncertainty: CIMG stock is now highly speculative. The combination of existing and new compliance issues creates immense uncertainty about CIMG's future on Nasdaq.
• Expect High Volatility: The stock price will likely experience significant swings based on any news, rumors, or lack of information.
• Illiquidity Risk: If delisted, CIMG's shares would likely move to less regulated over-the-counter (OTC) markets. Trading on OTC markets is often difficult and less transparent, typically resulting in a substantial decline in stock value and liquidity.
• Monitor Closely: Keep a vigilant eye on official company announcements. Watch for the overdue 10-Q filing, updates on delay reasons, and the Nasdaq Hearings Panel's review outcome. Without current financials, making informed decisions is nearly impossible.